Philadelphia-area medical device company RTM Vital Signs develops wearable and implantable systems that continuously monitor respiratory and cardiac health in real time. Its AI-driven RTMsense respiratory system received FDA 510(k) clearance in 2025, while the company’s cardiac monitoring technology is supported by 13 issued patents. Founded by executives Nance Dicciani and Denise Devine alongside anesthesiologist and medical-device inventor Dr. Jeff Joseph, RTM also received first prize for innovation at the 2023 American Society of Anesthesiology Conference.
FDA 510(k) Clearance for RMS GEN I
FDA Breakthrough Device Designation
Compliance program